All
  • All
  • Insight
  • Research Services
  • Preclinical CRO
  • Animal Resource Bank

Latest News

Focusing on cutting-edge technologies and research advancements,
sharing Aniphe BioLab’s achievements in scientific innovation, Professional insights
and practical experience in the fields of laboratory animals and preclinical research.

Bleomycin-induced pulmonary fibrosis model in mice

  Pulmonary fibrosis is a group of diseases characterized by irreversible lung damage resulting from abnormal tissue repair, with high mortality, extremely poor prognosis, and an unclear pathogenesis; currently, there are no specific therapeutic agents available. Based on a mouse model of pulmonary fibrosis induced by bleomycin (BLM), we aim to further identify biomarkers for pulmonary fibrosis, thereby providing a scientific foundation for in-depth investigation into its pathogenic mechanisms, preclinical evaluation of potential therapies, and the development of novel drugs.

  Modeling method

  Species and strain of the animal: BALB/c mice

  Animal sex: Female

  Animal age: 6 weeks old

  Animal weight: 20–25 g

  Preparation environment: Barrier environment

  Preparation period: 4 weeks

  Preparation method: A pulmonary fibrosis model was established by intratracheal administration of bleomycin (BLM).

  Evaluation criteria

  (1) Sampling and Observation

  (2) Histopathological Examination

  Results Display

  ●Histopathological Examination●

  Comparison between the normal group and the model group: In the lung tissue of model mice, interstitial capillaries exhibited congestion and dilation, alveolar walls became thickened and even ruptured, and the alveolar spaces showed inflammatory cell infiltration dominated by neutrophils.